President Obama's effort to overhaul the U.S. health system got an $80 billion shot in the arm from drugmakers. The pharmaceutical industry pledge includes $30 billion "that could be used" to provide discounts for medicines, said Reid H. Cherlin, a White House spokesman. That will help narrow a gap in Medicare drug coverage known as the doughnut hole. The allowances will encourage patients to remain on expensive brand-name medicines even when cheaper generic copies are available, Tim Anderson, an analyst with Sanford C. Bernstein & Co. in New York, said yesterday.
